Eisai to Push Efficacy of Careram in Combination with MTX, Low Drug Costs

Careram Launched on September 12 On September 12, Eisai launched its rheumatoid arthritis (RA) treatment Careram (iguratimod). The company will push the usefulness of Careram, a small molecule compound, as a new treatment option for RA patients who have been...read more